相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic epidemiology of cancer
Timothy M. Barrow et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Trends in breast cancer incidence and mortality in the United States: implications for prevention
Adetunji T. Toriola et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis
Liang Wu et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
Corinna Eichelser et al.
CLINICAL CHEMISTRY (2013)
Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2012)
Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies
Nathalie Druesne-Pecollo et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer
Patrick G. Morris et al.
BREAST JOURNAL (2012)
Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer
R. Verma et al.
BRITISH MEDICAL BULLETIN (2012)
Childhood cancer mortality in Australia
Danny R. Youlden et al.
CANCER EPIDEMIOLOGY (2012)
The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women
Jyothi S. Prabhu et al.
TUMOR BIOLOGY (2012)
Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries
V. A. McCormack et al.
ANNALS OF ONCOLOGY (2011)
Breast cancer statistics, 2011
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
Amanda I. Phipps et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
So Yeon Park et al.
CLINICAL CANCER RESEARCH (2010)
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society
Hirotaka Iwase et al.
BREAST CANCER (2010)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion
Ana Gutierrez-Fernandez et al.
CANCER RESEARCH (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression
Simon Hughes et al.
CLINICAL CANCER RESEARCH (2007)
Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis
Julie Decock et al.
CANCER RESEARCH (2007)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Trends in breast cancer by race and ethnicity: Update 2006
C Smigal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer
HJ Huang et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
V Ambros
CELL (2003)
Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database
WF Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer
E Turpin et al.
ONCOGENE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Stage 0 to stage III breast cancer in young women
C Gajdos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
分享论文
